IBM and Inclusive Brains have initiated a collaborative partnership to enhance the performance of brain-machine interfaces by integrating advanced AI and quantum machine learning techniques. This joint study aims to develop technology for personalized machine-user interactions, moving from generic to bespoke solutions that cater to individual needs and cognitive diversity. The initiative will focus on responsible technology use, ethical considerations, and advancing healthcare accessibility. By leveraging IBM's AI and quantum expertise, the partnership seeks to improve brain activity classification accuracy, ultimately offering users greater autonomy and agency.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。